SCHEMBL20171370

SCHEMBL20171370

Cc1nc([C@H](Cc2ccc(NS(=O)O)cc2)NC(=O)OC(C)(C)C)cs1

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 20/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19775410 0.85 PTPRB (0.74) PTPRB
SCHEMBL3610945 0.84 PTPRB (1.00) PTPRB
SCHEMBL684268 0.84 PTPRB (1.00) PTPRB
SCHEMBL5122747 0.82 PTPRB (0.69) PTPRB
SCHEMBL5773296 0.82 PTPRB (0.69) PTPRB
SCHEMBL24052389 0.80 PTPRB (0.75) PTPRB
SCHEMBL14051421 0.80 PTPRB (0.66) PTPRB
SCHEMBL8587261 0.75 PTPRB (0.42) PTPRB
SCHEMBL24308822 0.74 PTPRB (0.81) PTPRB
SCHEMBL24308697 0.73 PTPRB (0.79) PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3323815-A1 HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE Aerpio Therapeutics, Inc. (US) 2018-05-23 EP disclosed